Insmed Incorporated
At a glance
EmployeesNot reported
In business since1999
HeadquartersBridgewater, NJ
US patents63
SAM.gov UEIGLE1HZQ47JW6
CAGE code4HSZ2
Incorporated inVA
- therapies
- healthcare
- gene therapy
- protein deimmunization
- RNA end-joining
- synthetic rescue
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Insmed Incorporated’s own job board on Workday, last checked OCT 28, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Associate Director, Corporate CommunicationsNJ Corporate Headquarters · posted OCT 28, 2026
- Director, Expert Marketing and EngagementNJ Corporate Headquarters · posted OCT 28, 2026
- Manager, Programming Infrastructure & Analytics EnablementNJ Corporate Headquarters · posted OCT 27, 2026
- Director of Field Medical ExcellenceNJ Corporate Headquarters · posted OCT 27, 2026
- Senior Clinical Trial ManagerNJ Corporate Headquarters · posted OCT 24, 2026
- Director, HCP Marketing LeadNJ Corporate Headquarters · posted OCT 24, 2026
- Manager, Post-Market Surveillance, Analytics and Reporting (PQC)NJ Corporate Headquarters · posted OCT 24, 2026
- Senior Director, Regulatory AffairsNJ Corporate Headquarters · posted OCT 23, 2026
- QMS Specialist, Quality AssuranceResearch Development Lab - San Diego · posted OCT 23, 2026
- Senior Manager, Facilities MaintenanceNJ Corporate Headquarters · posted OCT 22, 2026
100 more on the company’s board
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
63 US patents granted 2002–2025, 20 of them in the five years to SEP 2025.
Pharmaceuticals 61Organic fine chemistry 2
- Methods for treating pulmonary non-tuberculous mycobacterial infectionsUS 12,377,114 · granted AUG 5, 2025
- Methods for continuous manufacture of liposomal drug productsUS 12,290,600 · granted MAY 6, 2025
- Dry powder compositions of treprostinil prodrugs and methods of use thereofUS 12,201,725 · granted JAN 21, 2025
- Methods for treating pulmonary non-tuberculous mycobacterial infectionsUS 12,168,022 · granted DEC 17, 2024
- Methods for treating pulmonary non-tuberculous mycobacterial infectionsUS 12,168,021 · granted DEC 17, 2024
Newest 5 shown · Granted to Insmed Incorporated · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Insmed Incorporated | Bridgewater | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.